AZTherapies Competitors and Similar CompaniesClear all
AZTherapies's competitors and similar companies include ESSA Pharma, dMed, Apeloa Pharmaceutical and SciClone Pharmaceuticals.
 AZTherapies AZTherapies is a developer of pharmaceutical drugs designed to provide treatment for multiple neurodegenerations and neuroinflammation-related CNS diseases. |  ESSA Pharma ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer. |  dMed dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities. |  Apeloa Pharmaceutical Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products. |  SciClone Pharmaceuticals SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. | |
Founding Date | Founding Date 2011 | Founding Date 2009 | Founding Date 2016 | Founding Date 1989 | Founding Date 1989 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Boston, US HQ | Locations Vancouver, CA HQ Houston, US South San Francisco, US | Locations Morrisville, US HQ | Locations CN HQ | Locations Foster City, US HQ |
Employees | Employees 9 | Employees 35 | Employees 172 | Employees 7,060 | Employees 1102% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 240 m | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥9.7b (FY, 2025) | Revenue (est.) $160.1m (FY, 2016) |
Net income | Net income N/A | Net income ($28.5m) (FY, 2024) | Net income N/A | Net income ¥890.7m (FY, 2025) | Net income $30.7m (FY, 2016) |
Funding | |||||
Latest funding round | Latest funding round $ 33.6m (over 5 years ago) | Latest funding round N/A | Latest funding round $ 50m (almost 5 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 97.7m | Total funding raised $ 74.1m | Total funding raised $ 208m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ESSA Pharma
HQ
Vancouver, CA
Employees
35
ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer.
View companydMed
HQ
Morrisville, US
Employees
172
dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities.
View companyApeloa Pharmaceutical
HQ
CN
Employees
7,060
Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products.
View companySciClone Pharmaceuticals
HQ
Foster City, US
Employees
110↓ 2% decrease
SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders.
View company